Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma

By Erin M. Bange, MD; Abigail Doucette, MPH; Peter E. Gabriel, MD, MSE; Florence Porterfield, BS; James J. Harrigan, MD, PharmD; Robin Wang, BA; Andrzej P. Wojcieszynski, MD; Ben Boursi, MD; Bethany I. Mooney, CRNP, MSN; Kim A. Reiss, MD; Ronac Mamtani, MD, MSCE